Amedisys Stock Forecast for 2023 - 2025 - 2030
Updated on 04/19/2024
Amedisys Stock Forecast and Price Target
If the average 2024 price target of $101.00 recently set by two prominent experts for Amedisys is met, there would be a potential upside of approximately 11.26% from the last closing price in April, 2024. The high estimate is $101.00, and the low is $73.00. If you're looking to buy Amedisys stock, you may also want to check out its rivals.
11.26% Upside
Amedisys Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Amedisys's Price has fallen from $176.82 to $0.00 – a 100.00% decrease. In the next year, analysts predict that Fair Value will jump to $130.52 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that Fair Value will grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| WELL Stock Forecast | HAN-GINS Indxx Healthcare Inno... | Outperform |
17
|
$90.81 | Buy/Sell | $97.00 | 15.08% |
| UHS Stock Forecast | Universal Health Services | Outperform |
6
|
$153.65 | Buy/Sell | $162.38 | 21.71% |
| CHE Stock Forecast | Chemed Corp | Outperform |
18
|
$597.42 | Buy/Sell | $611.33 | 16.58% |
| ACHC Stock Forecast | Acadia Healthcare Company | Outperform |
15
|
$70.28 | Buy/Sell | $89.55 | 42.29% |
| OHI Stock Forecast | Omega Healthcare Investors | Outperform |
16
|
$29.98 | Buy/Sell | $32.43 | 8.41% |
Amedisys Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Amedisys's Revenue has grown, moving from $2.07B to $2.24B – an increase of 7.96%. In the next year, analysts predict that Revenue will jump to $2.34B – up 4.56% from the current level. Looking ahead to seven years, experts forecast that Revenue will grow by 11.70%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| EHC Stock Forecast | Encompass Health | Buy |
18
|
$78.62 | Buy/Sell | $84.00 | 14.47% |
| ENSG Stock Forecast | The Ensign Group | Outperform |
18
|
$116.48 | Buy/Sell | $119.25 | 14.18% |
| OPCH Stock Forecast | Option Care Health | Buy |
14
|
$30.90 | Buy/Sell | $0.00 | 25.57% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SGRY Stock Forecast | Surgery Partners | Buy |
13
|
$23.42 | Buy/Sell | $43.20 | 83.60% |
| SEM Stock Forecast | Select Medical Holdings | Outperform |
16
|
$26.43 | Buy/Sell | $32.80 | 36.21% |
| IART Stock Forecast | Integra LifeSciences Holdings | Hold |
16
|
$31.63 | Buy/Sell | $46.60 | 37.53% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CTRE Stock Forecast | CareTrust REIT | Outperform |
16
|
$23.74 | Buy/Sell | $24.75 | 5.31% |
| AMN Stock Forecast | AMN Healthcare Services | Outperform |
16
|
$56.30 | Buy/Sell | $86.13 | 34.10% |
| NHI Stock Forecast | National Health Investors | Hold |
14
|
$53.64 | Buy/Sell | $62.17 | 2.54% |
Amedisys EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Amedisys's EBITDA has gone down from $242.85M to $216.91M – a 10.68% drop. In the coming year, analysts are expecting an increase in EBITDA, predicting it will reach $250.17M – an increase of 15.33%. Over the next seven years, experts anticipate that EBITDA growth for Amedisys will be 15.43%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| USPH Stock Forecast | U.S. Physical Therapy | Outperform |
18
|
$97.49 | Buy/Sell | $108.40 | 23.09% |
| NHC Stock Forecast | National HealthCare | - |
18
|
$87.95 | Buy/Sell | $47.00 | -100.00% |
| ADUS Stock Forecast | Addus HomeCare | Buy |
16
|
$97.16 | Buy/Sell | $111.14 | 8.07% |
Amedisys EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Amedisys's EBIT has fallen from $214.05M to $193.07M – a 9.80% decrease. In the next year, analysts predict that EBIT will reach $223.66M – an increase of 15.84%. For the next seven years, the forecast is for EBIT to grow by 14.81%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| LTC Stock Forecast | LTC Properties | Hold |
14
|
$31.68 | Buy/Sell | $34.00 | 7.32% |
| BKD Stock Forecast | Brookdale Senior Living | Outperform |
10
|
$6.52 | Buy/Sell | $6.48 | 18.87% |
| MD Stock Forecast | Pediatrix Medical Group | Hold |
12
|
$8.81 | Buy/Sell | $9.86 | 2.16% |
Amedisys EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Amedisys's EPS has fallen from $6.11 to $0.00 – a 100.00% decrease. In the next year, analysts predict that EPS will jump to $4.51 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that EPS will grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CYH Stock Forecast | Community Health Systems | Outperform |
11
|
$2.78 | Buy/Sell | $4.98 | 52.88% |
| PNTG Stock Forecast | The Pennant Group | Outperform |
14
|
$19.89 | Buy/Sell | $14.50 | 10.61% |
| OFIX Stock Forecast | Orthofix Medical | Hold |
10
|
$13.02 | Buy/Sell | $18.00 | 15.21% |
.jpg)